Evidence map›Paper›PMID 35625620›Full record

ArticleBiomolecules2022

Matrix Metalloproteinases in Health and Disease in the Times of COVID-19.

Carlos Fernandez-Patron, Eugenio Hardy

Abstract readEditorial
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carlos Fernandez-PatronDepartment of Biochemistry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Eugenio HardyCenter of Molecular Immunology, P.O. Box 16040, Havana 11600, Cuba.

Funding

STAG2 modulates environmental toxicant exposures and epigenomic heterogeneityR01ES034250 · NIEHS · ROSWELL PARK CANCER INSTITUTE CORP · PI Joyce Ellen Ohm · 2022 to 2026
$3.0M
NIEHS NIH HHS R01 ES034250
6 · The paper itself

Abstract

Much has been written about matrix metalloproteinases (MMPs) in health and disease conditions, but their roles in the setting of COVID-19 and associated illnesses remain understudied [...].

Indexed as

COVID-19HumansMatrix MetalloproteinasesMatrix Metalloproteinases

Identifiers

PMID35625620
PMCPMC9138430

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.